Eye and Growth in Adolescents Born Moderate-to-late Preterm
Ocular Morphology and Visual Function in Relation to Growth, Metabolic, Cardiovascular, and Neuropsychiatric Status, and Quality of Life in Adolescents Born Moderate-to-late Preterm
1 other identifier
observational
100
1 country
1
Brief Summary
During recent years, the interest in studying the risks of being born moderate-to-late preterm (MLP), defined as birth between gestational week 32 to 36, has increased. Today the investigators know that morbidity and mortality are significantly higher in these individuals compared to individuals born full-term. However, few studies have focused on the development of the eye in MLP individuals. The purpose of the study is to evaluate eye morphology and visual function in relation to growth, metabolism, blood pressure, neuropsychiatric factors, and quality of life in adolescents born MLP. The results of the examinations will be compared to an age-matched control group. The study will evaluate the structural, functional, and metabolic aspects of the eye with the hypothesis that early eye abnormalities may detect the risk of developing metabolic and cardiovascular diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 22, 2019
CompletedStudy Start
First participant enrolled
October 28, 2019
CompletedFirst Posted
Study publicly available on registry
December 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedMay 6, 2022
January 1, 2021
1.9 years
August 22, 2019
May 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Optic disc area.
Optic disc area measured with Optical coherence tomography (OCT, Topcon).
Through study completion, an average of 6 months
Visual acuity.
Visual acuity measured with Early Treatment Diabetic Retinopathy Study (ETDRS) scores.
Through study completion, an average of 6 months.
Blood pressure.
Systolic and diastolic blood pressure measured with blood pressure cuffs.
Through study completion, an average of 6 months.
Blood concentration of Hemoglobin A1c (HbA1c).
Blood samples of HbA1c.
Through study completion, an average of 6 months.
Autism Spectrum Screening Questionnaire (ASSQ).
The ASSQ consists of 27 items and is scored using a likert scale, with the following alternatives: "not true" (0 points), "somewhat true" (1 point) and "certainly true" (2 points).
Through study completion, an average of 6 months.
Pediatric Quality of Life Inventory (PedsQL).
PedsQL is a questionnaire measuring health-related quality of life in children and adolescents aged 2 to 18 years. It consists of 23 items including physical functioning (8 items), emotional functioning (5 items), social functioning (5 items) and school functioning (5 items). It has a 5-point response scale: "never a problem" (0 points), "almost never a problem" (1 point), "sometimes a problem" (2 points), "often a problem" (3 points), "almost always a problem" (4 points).
Through study completion, an average of 6 months.
Weight.
Weight measured in kilograms.
Through study completion, an average of 6 months
The Swanson, Nolan, and Pelham Rating Scale (SNAP-IV).
Screening questionnaire for attention deficit hyperactivity disorder (ADHD) consisting of 26 items rated on a 4-point scale: "not at all" (0 points), "just a little" (1 point), "quite a bit" (2 points) and "very much" (3 points).
Through study completion, an average of 6 months.
Refraction.
Visual refraction measured with an autorefractor (Topcon).
Through study completion, an average of 6 months.
Height.
Height measured in meters.
Through study completion, an average of 6 months.
Study Arms (2)
Moderate-to-late preterm group
Full-term group
Interventions
Structural, functional and metabolic eye examinations
Eligibility Criteria
Year 2002 to 2004, 247 children born moderate-to-late preterm i Gothenburg, Sweden, were enrolled in a prospective, longitudinal and population-based cohort study. These children will be asked to participate in the present follow-up study 15 years later. The age-matched control group born full-term will be recruited from schools in Gothenburg.
You may qualify if:
- Born moderate-to-late preterm.
- Born in Gothenburg, Sweden.
- Born between years 2002 and 2004.
You may not qualify if:
- Chromosomal abnormalities.
- Syndromes.
- Severe malformations.
- Asphyxia.
- Language difficulties.
- Psychosocial problems at birth.
- Severe maternal illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of neuroscience and physiology
Gothenburg, Västra Götaland County, SE-413 45, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2019
First Posted
December 9, 2019
Study Start
October 28, 2019
Primary Completion
October 1, 2021
Study Completion
October 1, 2021
Last Updated
May 6, 2022
Record last verified: 2021-01